Technology
Health
Pharmaceutical

Eton Pharmaceuticals

$7.80
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.06 (0.84%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell ETON and other stocks, options, ETFs, and crypto commission-free!

About

Eton Pharmaceuticals, Inc. engages in the development and commercialization of prescription drug products. Its portfolio consists of Injectable and Ophthalmic products pipelines. Read More The company was founded in April 2017 and is headquartered in Deer Park, IL.

Employees
9
Headquarters
Deer Park, Illinois
Founded
2017
Market Cap
137.34M
Price-Earnings Ratio
Dividend Yield
Average Volume
31.77K
High Today
$7.95
Low Today
$7.64
Open Price
$7.65
Volume
4.52K
52 Week High
$8.11
52 Week Low
$5.70

Collections

Technology
Health
Pharmaceutical
2018 IPO
US
North America

News

ReutersFeb 11

BRIEF-Eton Pharmaceuticals Enters License Agreement For Two Branded Hospital Products

Feb 11 (Reuters) - Eton Pharmaceuticals Inc: * ETON PHARMACEUTICALS ENTERS INTO LICENSE AGREEMENT FOR TWO BRANDED HOSPITAL PRODUCT CANDIDATES * ETON PHARMACEUTICALS INC - ET-203 NDA EXPECTED TO BE SUBMITTED BY Q3 2019 * ETON PHARMACEUTICALS INC - ET-202 NDA WAS SUBMITTED IN DECEMBER 2018; PDUFA DATE EXPECTED TO BE IN Q4 2019 * ETON PHARMACEUTICALS - TO PAY SINTETICA $3 MILLION UPON EXECUTION OF AGREEMENTS, OBLIGATED TO PAY ADDITIONAL $750,000 UPON APPROVAL OF EACH PRODUCT * ETON PHARMACEUTICALS - ENTER...

57

Earnings

-$0.78
-$0.69
-$0.61
-$0.52
Q3 2018
Q4 2018
Estimated
Actual
Expected Mar 28, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.